Relative risk of progressive glaucomatous visual field loss in patients enrolled and not enrolled in a prospective longitudinal study

Archives of Ophthalmology

Volumn 124, Issue 10, 2006, Pages 1405-1408

  Henson, David B ^a   Shambhu, Siddesh ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GLAUCOMA; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; VISUAL FIELD; VISUAL FIELD DEFECT;

DISEASE PROGRESSION; GLAUCOMA; HUMANS; LONGITUDINAL STUDIES; PATIENT PARTICIPATION; RETROSPECTIVE STUDIES; RISK; VISION DISORDERS; VISUAL FIELDS;

EID: 33749567824     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.10.1405     Document Type: Article

References (22)

1. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
2. Lichter PR, Musch DC, Gillespie BW, et al; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
3. Martus P, Stroux A, Budde WM, Mardin CY, Korth M, Jonas JB. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma. Am J Ophthalmol. 2005;139:999-1009.
4. Katz J, Congdon N, Friedman DS. Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment. Arch Ophthalmol. 1999;117:1137-1142.
5. Nouri-Mahdavi K, Caprioli J, Coleman AL, Hoffman D, Gaasterland D. Pointwise linear regression for evaluation of visual field outcomes and comparison with the advanced glaucoma intervention study methods. Arch Ophthalmol. 2005;123:193-199.
6. Boden C, Blumenthal EZ, Pascual J, et al. Patterns of glaucomatous visual field progression identified by three progression criteria. Am J Ophthalmol. 2004;138:1029-1036.
7. Jonas JB, Martus P, Horn FK, Junemann A, Korth M, Budde WM. Predictive factors of the optic nerve head for development or progression of glaucomatous visual field loss. Invest Ophthalmol Vis Sci. 2004;45:2613-2618.
8. Nicolela MT, McCormick TA, Drance SM, Ferrier SN, LeBlanc RP, Chauhan BC. Visual field and optic disc progression in patients with different types of optic disc damage - a longitudinal prospective study. Ophthalmology. 2003;110:2178-2184.
9. Chauhan BC, McCormick TA, Nicolela MT, LeBlanc RP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma - comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001;119:1492-1499.
10. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 4: comparison of treatment outcomes within race. Ophthalmology. 1998;105:1146-1164.
11. The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up-study, 7: results. Glaucoma Laser Trial Research Group. Am J Ophthalmol. 1995;120:718-731.
12. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498-505.
13. Susanna R, Vessani RM, Sakata L, Zacarias LC, Hatanaka M. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma. Br J Ophthalmol. 2005;89:1298-1301.
14. Spry PGD, Sparrow JM, Diamond JP, Harris HS. Risk factors for progressive visual field loss in primary open angle glaucoma. Eye. 2005;19:643-651.
15. Kwon YH, Kim CS, Zimmerman E, Alward WL, Hayreh SS. Rate of visual field loss and long-term visual outcome in primary open-angle glaucoma. Am J Ophthalmol. 2001;132:47-56.
16. Kwartz AJ, Henson DB, Harper RA, Spencer AF, McLeod D. The effectiveness of the Heidelberg Retinal Tomograph and laser diagnostic glaucoma scanning system (GDx) in detecting and monitoring glaucoma. Health Technol Assess. 2005;9(46). http://www.ncchta.org/index.htm. Accessed August 11, 2006.
17. Anderson DR, Patella VM. Automated Static Perimetry. 2nd ed. St Louis, Mo: Mosby Inc; 1999.
18. Artes PH, Iwase A, Ohno Y, Kitazawa Y, Chauhan BC. Properties of perimetric threshold estimates from full threshold, SITA standard, and SITA fast strategies. Invest Ophthalmol Vis Sci. 2002;43:2654-2659.
19. Wood JM, Wild JM, Hussey MK, Crews SJ. Serial examination of the normal visual field using Octopus automated projection perimetry evidence for a learning effect. Acta Ophthalmol (Copenh). 1987;65:326-333.
20. Reardon G, Schwartz GF, Mozaffari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol. 2004;137:S3-S12.
21. Rotchford AP, Murphey KM. Compliance with timolol treatment in glaucoma. Eye. 1998;12:234-236.
22. Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology. 2003;110:726-733.